Complete Filing Data
Pharvaris N.V. reported Cash And Cash Equivalents of $280.73 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Pharvaris N.V. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Research And Development Expense | $98.6M | $65.6M | $57.4M | $35.8M | $19.5M | $5.7M | $3.6M |
| Profit Loss From Operating Activities | -$132.4M | -$99.8M | -$75.7M | -$42.7M | -$26.1M | -$8.0M | -$4.3M |
| Profit Loss | -$134.2M | -$100.9M | -$76.3M | -$42.7M | -$26.0M | -$8.0M | -$4.3M |
| General And Administrative Expense | $47.1M | $31.3M | $29.3M | $18.3M | $5.5M | $2.3M | $668.1K |
| Comprehensive Income Attributable To Owners Of Parent | -$134.1M | -$100.9M | -$76.3M | -$42.7M | -$26.0M | -$8.0M | -$4.3M |
| Income Tax Expense Continuing Operations | $1.8M | $1.0M | $679.1K | $70.1K | -$83.3K | $0.00 | $0.00 |
| Profit Loss Before Tax | -$132.4M | -$99.8M | -$75.7M | -$42.7M | -$26.1M | -$8.0M | -$4.3M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $152.3K | -$57.9K | $17.4K | $30.3K | -$4.4K | ||
| Comprehensive Income | -$134.2M | -$100.9M | -$76.3M | -$42.7M | -$26.0M | -$8.0M | -$4.3M |
| Adjustments For Income Tax Expense | -$2.8M | -$1.1M | -$182.8K | -$27.6K | $0.00 | ||
| Current Receivables From Taxes Other Than Income Tax | $2.5M | $615.5K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $280.7M | $391.2M | $161.8M | $209.4M | $98.6M | $20.3M | $5.4M | $4.8M |
| Property Plant And Equipment | $667.0K | $223.7K | $193.5K | $108.1K | $48.5K | $12.9K | $0.00 | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $538.1K | $90.0K | $124.3K | $130.0K | $43.0K | $13.5K | $0.00 | |
| Cash Flows From Used In Operating Activities | -$120.1M | -$93.0M | -$67.2M | -$44.6M | -$21.5M | -$6.7M | -$3.9M | |
| Cash Flows From Used In Investing Activities | -$538.1K | -$90.0K | -$124.3K | -$130.0K | -$43.0K | -$13.5K | $0.00 | |
| Cash Flows From Used In Financing Activities | $2.7M | $325.4M | $8.7M | $143.7M | $101.2M | $21.6M | $4.5M | |
| Adjustments For Decrease Increase In Trade Account Receivable | -$34.3K | -$41.1K | $317.6K | -$130.5K | -$358.7K | -$184.4K | -$48.0K | |
| Adjustments For Decrease Increase In Other Current Assets | -$136.4K | -$953.9K | -$2.5M | $239.9K | -$493.2K | -$24.9K | $0.00 | |
| Issue Of Equity | $12.6K | $342.6M | $9.5M | $157.2M | $102.5M | $22.5M | $4.5M | |
| Rightofuse Assets | $813.8K | $231.9K | $433.0K | $243.3K | ||||
| Adjustments For Increase Decrease In Trade And Other Payables | $1.7M | -$4.2M | $3.9M | $1.7M | $329.2K | $274.5K | $182.6K | |
| Adjustments For Increase Decrease In Accrued Liabilities | $4.4M | -$695.8K | $6.7M | -$196.8K | $2.1M | $1.2M | ||
| Trade And Other Current Payables | $4.6M | $2.9M | $6.7M | $2.5M | $830.9K | $517.8K | ||
| Retained Earnings | -$402.3M | -$265.9M | -$164.2M | -$87.6M | -$44.5M | -$18.5M | ||
| Other Current Assets | $5.7M | $5.6M | $4.6M | $1.5M | $1.8M | $47.5K | ||
| Liabilities | $23.6M | $14.6M | $18.5M | $7.1M | $5.3M | $1.9M | ||
| Equity And Liabilities | $291.4M | $398.7M | $167.7M | $212.1M | $101.1M | $20.6M | ||
| Assets | $291.4M | $398.7M | $167.7M | $212.1M | $101.1M | $20.6M | ||
| Noncurrent Lease Liabilities | $639.0K | $43.6K | $249.4K | $150.8K | ||||
| Current Lease Liabilities | $222.4K | $195.3K | $187.4K | $99.4K | ||||
| Current Tax Payable | $601.2K | $429.9K | $461.3K | $126.2K | $16.1K | |||
| Deferred Tax Assets | $474.3K | $387.5K | $259.8K | $172.1K | ||||
| Trade And Other Current Receivables | $382.5K | $700.1K | $569.6K | $210.8K | ||||
| Value Added Tax Receivables | $457.8K | $423.5K | $382.5K | |||||
| Current Deferred Tax Assets | $172.1K | $99.3K | $0.00 | |||||
| Adjustments For Decrease Increase In Accrued Liabilities | $2.1M | $1.2M | $156.9K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$118.0M | $232.3M | -$58.6M | $98.9M | $79.7M | $14.9M | $590.2K |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $7.5M | -$2.9M | $11.1M | $11.8M | -$1.4M | $0.00 | $0.00 |
| Proceeds From Issuing Shares | 9.6M | 156.8M | 102.5M | 22.5M | 4.5M | ||
| Payments For Share Issue Costs | $17.3M | $840.0K | $13.2M | $1.3M | $836.2K | $0.00 | |
| Payments Of Lease Liabilities Classified As Financing Activities | $159.7K | $220.5K | $119.5K | $0.00 | $0.00 | ||
| Proceeds From Issue Of Shares And Pre Funded Warrants | 2.2M | 342.9M | 9.6M | 156.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-2.48 | $-2.63 | $-2.27 | $-1.40 | |||
| Basic Earnings Loss Per Share | $-2.48 | $-2.63 | $-2.27 | $-1.40 | |||
| Basic And Diluted Earnings Loss Per Share1 | $-2.27 | $-1.40 | $-5.36 | $-1.66 | |||
| Basic And Diluted Earnings Loss Per Share | $-5.36 | $-1.66 | $-0.89 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Operating Expense | $145.7M | $96.9M | $86.7M | $54.1M | $25.0M | $8.0M | $4.3M |
| Reclassification Adjustments On Exchange Differences On Translation Net Of Tax | -$152.3K | $57.9K | -$17.4K | -$30.3K | $4.4K | ||
| Finance Income Cost | $13.3M | -$2.9M | $11.1M | $11.5M | -$1.1M | -$16.9K | |
| Depreciation Expense | $269.6K | $257.6K | $152.9K | $77.4K | $7.4K | $549.00 | $0.00 |
| Issued Capital | $6.5M | $6.3M | $4.1M | $4.0M | $235.7K | $131.0K | |
| Increase Decrease Through Sharebased Payment Transactions | $16.2M | $10.7M | $11.3M | $8.2M | $1.6M | $116.1K | $100.7K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$7.3M | $2.8M | -$11.1M | -$11.8M | $1.4M | -$3.7K | $3.0K |
| Adjustments For Sharebased Payments | $16.2M | $10.7M | $11.3M | $8.2M | $1.6M | $116.1K | $100.7K |
| Share Issue Related Cost | -$592.0K | $17.7M | $307.7K | $13.2M | $1.0M | $836.2K | |
| Adjustment For Interest Received Paid | $5.4M | $237.0K | -$144.2K | -$267.7K | -$46.6K | ||
| Share Premium | $623.6M | $615.8M | $289.2M | $278.7M | $138.0M | $36.6M | |
| Other Reserves | $39.7M | $27.9M | $20.2M | $9.8M | $2.0M | $392.1K | |
| Accruals Classified As Current | $17.6M | $11.1M | $10.9M | $4.3M | $4.5M | $1.4M | |
| Reserve Of Exchange Differences On Translation | $137.7K | -$14.6K | $43.3K | $25.9K | -$4.4K | ||
| Settlement Of Share Based Payments | $116.8K | -$502.2K | -$213.5K | -$330.2K | |||
| Adjustments For Finance Income Cost | $5.4M | $204.0K | -$39.3K | -$267.7K | |||
| Adjustments For Finance Costs | $39.3K | $267.7K | $98.7K | $0.00 | $0.00 | ||
| Tax Effect On Transaction Costs | $851.7K | $714.7K | $257.7K | ||||
| Transaction Costs | -$592.0K | $17.3M | $840.0K | ||||
| Finance Costs | $1.1M | $16.9K | $380.00 | ||||
| Adjustments For Interest Paid | -$46.6K | $0.00 | $0.00 | ||||
| Increase In Par Value | -$1.00 |
Most recent annual filing with the SEC: April 7, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.